Financials Hokuyaku Takeyama Holdings,Inc.

Equities

3055

JP3843360003

Pharmaceuticals

Delayed Sapporo S.E. 07:06:56 14/05/2024 am IST 5-day change 1st Jan Change
831 JPY -2.00% Intraday chart for Hokuyaku Takeyama Holdings,Inc. -1.77% +5.46%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 19,978 18,031 16,736 17,492 14,895 13,906
Enterprise Value (EV) 1 -689 -2,858 -4,796 -2,923 -6,179 -4,101
P/E ratio 9.48 x 8.61 x 8.19 x 11.8 x 5.35 x 5.13 x
Yield 2.01% 2.22% 2.39% 1.99% 2.58% 3.16%
Capitalization / Revenue 0.09 x 0.08 x 0.07 x 0.07 x 0.06 x 0.05 x
EV / Revenue -0 x -0.01 x -0.02 x -0.01 x -0.02 x -0.02 x
EV / EBITDA -0.18 x -0.79 x -1.13 x -1.06 x -1.86 x -1.07 x
EV / FCF -0.15 x -2.66 x -7.54 x 2 x -23.8 x 1.13 x
FCF Yield -667% -37.5% -13.3% 50% -4.2% 88.1%
Price to Book 0.41 x 0.35 x 0.32 x 0.32 x 0.27 x 0.24 x
Nbr of stocks (in thousands) 23,643 23,539 23,539 23,168 22,568 21,968
Reference price 2 845.0 766.0 711.0 755.0 660.0 633.0
Announcement Date 28/06/18 28/06/19 26/06/20 30/06/21 30/06/22 29/06/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 2,27,788 2,35,153 2,43,102 2,39,494 2,48,369 2,61,979
EBITDA 1 3,754 3,608 4,256 2,751 3,327 3,842
EBIT 1 2,542 2,488 3,027 1,483 2,132 2,647
Operating Margin 1.12% 1.06% 1.25% 0.62% 0.86% 1.01%
Earnings before Tax (EBT) 1 3,466 3,364 3,390 2,547 3,758 4,228
Net income 1 2,159 2,099 2,043 1,492 2,804 2,729
Net margin 0.95% 0.89% 0.84% 0.62% 1.13% 1.04%
EPS 2 89.12 88.93 86.79 63.98 123.4 123.4
Free Cash Flow 1 4,598 1,073 635.9 -1,461 259.5 -3,614
FCF margin 2.02% 0.46% 0.26% -0.61% 0.1% -1.38%
FCF Conversion (EBITDA) 122.48% 29.73% 14.94% - 7.8% -
FCF Conversion (Net income) 212.96% 51.11% 31.12% - 9.25% -
Dividend per Share 2 17.00 17.00 17.00 15.00 17.00 20.00
Announcement Date 28/06/18 28/06/19 26/06/20 30/06/21 30/06/22 29/06/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period:
Estimates

Balance Sheet Analysis

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 20,667 20,889 21,532 20,415 21,074 18,007
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 4,598 1,073 636 -1,461 260 -3,614
ROE (net income / shareholders' equity) 4.47% 4.19% 3.94% 2.79% 5.11% 4.83%
ROA (Net income/ Total Assets) 1.31% 1.25% 1.48% 0.7% 0.99% 1.2%
Assets 1 1,64,257 1,68,122 1,38,078 2,12,173 2,83,921 2,26,680
Book Value Per Share 2 2,085 2,171 2,240 2,346 2,461 2,614
Cash Flow per Share 2 875.0 888.0 916.0 882.0 935.0 820.0
Capex 1 357 1,636 3,525 2,395 2,228 1,700
Capex / Sales 0.16% 0.7% 1.45% 1% 0.9% 0.65%
Announcement Date 28/06/18 28/06/19 26/06/20 30/06/21 30/06/22 29/06/23
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 3055 Stock
  4. Financials Hokuyaku Takeyama Holdings,Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW